News

BEIJING -- China has rolled out its domestically developed nine-valent human papillomavirus (HPV) vaccine, administering the first dose on Tuesday in the city of Xiamen, to expand cervical cancer protection for females aged 9 to 45. Health authorities s...

Shanghai East Hospital said Friday that a patient from Hainan province has become the latest beneficiary of a spinal endoscopic technology known as uni-port bichannel dual-media, or UBD, which reduces incisions from about 20 centimeters to 1 cm. The inn...

Chinese scientists have made a breakthrough in Chikungunya fever detection by developing a kit solution allowing for the entire detection process within just 30 minutes, according to a laboratory based in Guangzhou, the capital of Guangdong province. The ...

The sector is heavily reliant on imports, creating significant opportunities for local manufacturing, says Sylvana Quader Sinha, founder of Praava Health. Experts at a session today (10 April) urged investors to explore opportunities in Bangladesh's med...

The 92nd China International Medical Equipment Fair (CMEF), widely regarded as the global barometer of the medical industry, will be held from September 26 to 29 at the Canton Fair Complex in Guangzhou, China. Under the theme “Health · Innovat...

China's AI breakthrough set to be game-changer for early cancer detection HANGZHOU -- In a landmark development for medical technology, Chinese researchers have unveiled an artificial intelligence system capable of detecting early-stage stomach cancer...

With cases of diabetes rising significantly over the past 18 years, Chinese medical experts are urging people to adopt healthier lifestyles. A recent study found that 233 million people in China had diabetes as of 2023, a 163 percent increase from 2005....

Recently, the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences published a groundbreaking research result in Nature Nanotechnology. The magnetic nanorobot system developed by them has for the first time achieved a full-chain treatment of "crossing the blood-brain barrier - precise navigation - targeted blasting", bringing a revolutionary solution to brain diseases such as Alzheimer's disease.

Washington, June 12, 2024 - The U.S. Food and Drug Administration (FDA) today accelerated the approval of the gene therapy "SOD1-ASO" (brand name Toferson) developed by Swiss pharmaceutical giant Novartis for the treatment of amyotrophic lateral sclerosis (ALS) caused by mutations in the superoxide dismutase 1 (SOD1) gene. This is the world's first gene therapy drug targeting a specific subtype of ALS.